# Gen1e Lifesciences Inc.

Canonical: https://abierto.us/vendors/gen1e-lifesciences-inc-ftd3fakef2z8

- UEI: FTD3FAKEF2Z8
- CAGE: 87VX4
- Location: Palo Alto, CA
- Awards in window: 1 (3 transactions), $0 obligated, March 12, 2025 to December 19, 2025

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 1 awards, $0

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $0

## Competition

- Full and Open Competition: 1 awards

## Largest awards

- 75A50123C00063 (definitive contract): $0, Barda - Aspr / Daappo / Barda DCMA. Gen1e - This Contract Will Provide Support to Gen1e Lifesciences INC. (Gen1e), a US Company, for the Advancement of Patient Stratification and Endotyping Approaches as IT Develops GEN-1124, a Novel Treatment for Acute Respiratory Distress Syndrome (A. https://www.usaspending.gov/award/CONT_AWD_75A50123C00063_7505_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/gen1e-lifesciences-inc-ftd3fakef2z8.